| CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment H Mollanoori, H Shahraki, Y Rahmati, S Teimourian Human immunology 79 (12), 876-882, 2018 | 104 | 2018 |
| Therapeutic applications of CRISPR/Cas9 system in gene therapy H Mollanoori, S Teimourian Biotechnology letters 40, 907-914, 2018 | 68 | 2018 |
| Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs E Moghanloo, H Mollanoori, M Talebi, S Pashangzadeh, F Faraji, ... Translational Oncology 14 (6), 101070, 2021 | 27 | 2021 |
| Promising therapeutic approaches using CRISPR/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy H Mollanoori, Y Rahmati, B Hassani, MH Mehr, S Teimourian Genes & Diseases 8 (2), 146-156, 2021 | 26 | 2021 |
| Filaggrin gene polymorphisms in Iranian ichthyosis vulgaris and atopic dermatitis patients B Hassani, A Isaian, M Shariat, H Mollanoori, S Sotoudeh, V Babaei, ... International Journal of Dermatology 57 (12), 1485-1491, 2018 | 26 | 2018 |
| Havasi Mehr M, Teimourian S. Promising therapeutic approaches using CRISPR/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy H Mollanoori, Y Rahmati, B Hassani Genes Dis 8 (2), 146-156, 2021 | 9 | 2021 |
| MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: an integrated bioinformatics and experimental study Y Rahmati, M Alivand, H Mollanoori Computational Biology and Chemistry 92, 107458, 2021 | 7 | 2021 |
| Mutation characterization and heterodimer analysis of patients with leukocyte adhesion deficiency: Including one novel mutation S Teimourian, M De Boer, D Roos, A Isaian, E Moghanloo, S Lashkary, ... Immunology Letters 187, 7-13, 2017 | 7 | 2017 |
| Gene expression analysis in Kawasaki disease; bioinformatics and experimental approach Y Rahmati, H Mollanoori, N Kakavandi, A Nateghian, S Sayyahfar, ... Informatics in Medicine Unlocked 20, 100423, 2020 | 6 | 2020 |
| CASP5 and CR1 as potential biomarkers for Kawasaki disease: an Integrated Bioinformatics-Experimental Study Y Rahmati, H Mollanoori, S Najafi, S Esmaeili, MR Alivand BMC pediatrics 21 (1), 566, 2021 | 4 | 2021 |
| Constructing mRNA, miRNA, circRNA and lncRNA regulatory network by Analysis of microarray data in breast cancer B Hassani, H Mollanoori, F Pouresmaeili, Y Asgari, S Ghafouri-Fard Gene Reports 26, 101510, 2022 | 3 | 2022 |
| A novel human T17N-phospholamban variation in idiopathic dilated cardiomyopathy H Mollanoori, N Naderi, A Amin, B Hassani, H Shahraki, S Teimourian Gene Reports 12, 122-127, 2018 | 3 | 2018 |
| Indirect Molecular Diagnosis of Congenital Factor ΧІІІ Deficiency by Candidate Microsatellites and Single Nucleotide Polymorphisms H Shahraki, M Fathi, S Tabibian, O Sargazi-Aval, H Mollanoori, F Zaker, ... Iranian Journal of Pediatric Hematology and Oncology 10 (2), 114-130, 2020 | 1 | 2020 |
| Identification of 7 key age-related genes involved in Kawasaki disease, an integrated study by metaDE and weighted gene co-expression network analysis Y Rahmati, H Mollanoori, S Shafiee, S Esmaeili J Comput Chem Mol Model 4 (2), 392-402, 2020 | 1 | 2020 |
| Weighted correlation network analysis of multiple sclerosis: identifying key genes involved in disease progress Y Rahmatia, M Ghorbanib, H Mollanooria, F Ghorbanic Journal of Computational Chemistry and Molecular Modelling 4, 0 | 1 | |
| Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer H Mollanoori, Y Ghelmani, B Hassani, M Dehghani Scientific Reports 14 (1), 91, 2024 | | 2024 |
| Integrated whole transcriptome profiling of circRNAs reveals a convoluted crosstalk in competing endogenous RNAs regulatory network in Colorectal Cancer H Mollanoori, Y Ghelmani, B Hassani, M Dehghani | | 2023 |
| The founder effect?-FXIII deficiency in southeast Iran: A molecular study report H Shahraki, A Dorgalaleh, M Fathi, S Tabibian, S Teimourian, ... Journal of Cellular & Molecular Anesthesia 5 (4), 2020 | | 2020 |
| How to assess founder effect in patients with congenital factor XIII deficiency H Shahraki, A Dorgalaleh, M Fathi, S Tabibian, S Teimourian, ... International journal of hematology-oncology and stem cell research 14 (4), 265, 2020 | | 2020 |
| Screening the underlying molecular mechanisms involved in the development of heart failure H Mollanoori, Y Rahmati, B Hassani, S Esmaeili, K Amini, S Teimourian Meta Gene 25, 100743, 2020 | | 2020 |
Shahram Teimourian ( Professor)Iran university of medical sciences在 iums.ac.ir 的电子邮件经过验证
